ArticleJournal of cancer research and clinical oncology2019

Correction to: Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma.

Francesco Marampon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.